Legal Representation
Attorney
Frances M. Jagla
USPTO Deadlines
Next Deadline
2049 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2025-03-04)
Due Date
March 04, 2031
Grace Period Ends
September 04, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
9 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Mar 4, 2025 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Mar 4, 2025 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Jan 14, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jan 14, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jan 8, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Oct 25, 2024 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Oct 23, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Oct 10, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Apr 22, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of immunological disorders; pharmaceutical preparations for the treatment of auto-immune disorders; pharmaceutical preparations for the treatment of inflammatory disorders; pharmaceutical preparations for the treatment of graft versus host disorder (GVHD); pharmaceutical preparations for the treatment of hematological disorders; pharmaceutical preparations for the treatment of myeloproliferative disorders; pharmaceutical preparations for the treatment of skeletal or chondrocyte disorders; pharmaceutical preparations for the treatment of dermatological disorders
First Use Anywhere:
Jul 15, 2004
First Use in Commerce:
Jul 15, 2004
Class 016
Printed brochures, newsletters, and pamphlets in the fields of medical issues, procedures, disease symptoms, patient support and community building
First Use Anywhere:
Apr 30, 2004
First Use in Commerce:
Apr 30, 2004
Class 042
Scientific and medical research relating to oncological, viral, hematological, auto-immune, graft versus host, inflammatory, metabolic, myeloproliferative, skeletal or chondrocyte and dermatological disorders
First Use Anywhere:
Apr 30, 2004
First Use in Commerce:
Apr 30, 2004
Class 044
Providing medical information to healthcare providers and patients relating to oncological, viral, hematological, auto-immune, graft versus host, inflammatory, metabolic, myeloproliferative, skeletal or chondrocyte and dermatological disorders
First Use Anywhere:
Jul 16, 2004
First Use in Commerce:
Jul 16, 2004
Classification
International Classes
005
016
042
044